Two vaccine programs shared immovable launch dates and the review cycles of six different functions.
Pfizer · Abrysvo and Comirnaty
Challenge
Medical, legal, regulatory, engineering, production, and agency teams worked to different review cycles while depending on each other's output, against release dates that could not move. A delay anywhere became a launch risk everywhere, and no team had a shared view of which approvals were outstanding or which dependency was about to bind.
Action
Stage gates, dependency ownership, approval status, and escalation criteria were established across the Abrysvo and Comirnaty workstreams as one structure rather than one per brand, so an approval holding up a shared dependency was visible to both. MLR stage gates anchored the sequence, since medical, legal and regulatory review set the pace everything else had to fit around. The Release Readiness Dashboard put the state of every gate and dependency in front of the people who could act on it, and escalation criteria were agreed in advance so a blocked dependency had a named route rather than a meeting. Go-live criteria, escalation coverage, and hypercare staffing were confirmed before release.
Result
The delivered scope included five Abrysvo KOL FAQ videos and maternal materials, alongside Comirnaty HCP and global initiatives, released against dates that did not move. Hypercare was staffed before go-live rather than assembled after it, so the first issues raised after release reached owners who were already assigned to them.
